GSK3B and hepatocellular carcinoma: However, activation of GSK3β (dephosphorylation level) was not observed in BafA1-treated HCC cells compared with mock-treated cells (Fig. 2D), suggesting that GSK3β may not be implicated in BafA1-induced Cyclin D1 turnover in HCC cells.